Guided atracurium dosing in ICU patients
Part of Genetic & congenital, Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether using a device to guide the dosing of atracurium (a muscle relaxant) improves outcomes in critically ill ICU patients who need this medication for more than 48 hours. It focuses on patients with severe lung or heart conditions, such as ARDS or ECMO support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 20 years of age or older.
- You must be in the intensive care unit (ICU) and need a continuous infusion of atracurium (a muscle relaxant) for more than 48 hours.
- You must have one of the following conditions: severe ARDS (a serious lung condition with very low oxygen), post-cardiac arrest with targeted temperature management, or support with ECMO (a machine that helps your heart and lungs).
- You must not be pregnant, allergic to atracurium, or have severe asthma.
- You must not have a do-not-resuscitate (DNR) order or refuse to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at people who develop a new irregular heart rhythm called atrial fibrillation while in the intensive care unit (ICU). It tests an approach to help with that condition after critical illness, aiming to improve outcomes for those affected.
This trial studies whether a small dose of a muscle-relaxing medicine works safely for people having surgery under general anesthesia. You might be a candidate if you fit the age and surgical setup, and you don’t have certain health problems or medication issues.
This study tests whether partially relaxing the breathing-related muscles can help people with severe low oxygen while they are on a breathing machine. It may improve how well the lungs work by changing the way the muscles affect breathing.
This trial tests whether giving magnesium can lower the chance of developing new irregular heartbeat (atrial fibrillation) in critically ill adults in the ICU. If you are at risk but do not already have this rhythm issue, magnesium may help prevent it.
This trial tests different amounts of inspiratory muscle training (IMT) for patients who have a tracheostomy tube and are on a breathing machine in the intensive care unit. Researchers want to find the dose that helps most with recovery.
This study compares two ways of giving a muscle relaxant medicine to people who are on a breathing machine due to severe lung failure. It aims to find out which method helps improve breathing and recovery.
Hear when a new ARDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.